X4 Pharmaceuticals Inc [NASDAQ: XFOR] closed the trading session at $0.56.
The stocks have a year to date performance of -32.67 percent and weekly performance of -43.54 percent. The stock has been moved at -36.00 percent over the last six months. The stock has performed -43.54 percent around the most recent 30 days and changed -61.59 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 3.16M shares, XFOR reached to a volume of 3135604 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about X4 Pharmaceuticals Inc [XFOR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for XFOR shares is $4.12 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on XFOR stock is a recommendation set at 1.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
B. Riley Securities have made an estimate for X4 Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on December 12, 2023. While these analysts kept the previous recommendation, B. Riley Securities raised their target price to Buy. The new note on the price target was released on August 30, 2023, representing the official price target for X4 Pharmaceuticals Inc stock. Previously, the target price had yet another raise to $3, while Cantor Fitzgerald analysts kept a Overweight rating on XFOR stock.
The Average True Range (ATR) for X4 Pharmaceuticals Inc is set at 0.09 The Price to Book ratio for the last quarter was 91.50, with the Price to Cash per share for the same quarter was set at 0.48.
XFOR stock trade performance evaluation
X4 Pharmaceuticals Inc [XFOR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -43.54. With this latest performance, XFOR shares dropped by -43.54% in over the last four-week period, additionally sinking by -36.00% over the last 6 months – not to mention a drop of -69.97% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XFOR stock in for the last two-week period is set at 25.77, with the RSI for the last a single of trading hit 21.29, and the three-weeks RSI is set at 30.05 for X4 Pharmaceuticals Inc [XFOR]. The present Moving Average for the last 50 days of trading for this stock 0.9863, while it was recorded at 0.5897 for the last single week of trading, and 0.9433 for the last 200 days.
X4 Pharmaceuticals Inc [XFOR]: An insightful look at the core fundamentals
X4 Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.71 and a Current Ratio set at 3.71.
X4 Pharmaceuticals Inc [XFOR]: Institutional Ownership
The top three institutional holders of XFOR stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in XFOR stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in XFOR stock with ownership which is approximately 5.1238%.
